Retrieved from Rybelsus.com
The primary objective of the phase 3b SOUL trial was to evaluate the effects of oral semaglutide 14mg, in addition to standard of care, on reducing the risk of MACE in adults with type 2 diabetes at high risk for major cardiovascular events
The maximum retatrutide dose currently being studied in major Phase 3 obesity trials is 12mg once weekly
In addition to acting through the p38 pathway, GLP-1RAs also promote the increase of PKA levels via the cAMP-dependent pathway, which in turn prevents the phosphorylation of epidermal growth factor receptor (EGFR) and activator of transcription 3 (STAT3), resulting in the inactivation of the EGFR-STAT3 signaling pathway in tumor cells and subsequently downregulating several downstream effector genes such as myelocytomatosis oncogene (c-Myc), survivin, cyclin D1, Bcl-xl, and Bcl-2, thereby inducing apoptosis in tumor cells in a dose-dependent manner [70, 73]
Health Goal Pathways Every health journey is unique
Eli Lilly is expected to publish results in 2026